Accelerating Drug Discovery with Quantum Computing
Abstract
The evolution of molecular formulations into medications to treat or remedy diseases is the foundation of the pharmaceutical business. Therefore, it is crucial that the pharmaceutical industry devotes a full 15% of its sales to research and development, which accounts for more than 20% of all R&D expenditures across all productions in the global economy. The trial-and-error method is typically used to create drugs, which is not only expensive but also risky and difficult to complete. Drug companies may potentially save a huge money and time by using quantum computing to better understand drugs and their effects on people. By enabling businesses to undertake more drug discoveries and develop breakthrough medical treatments, these computer advancements have the potential to significantly boost efficiency and lead to a more productive pharmaceutical industry. Pharmaceutical research and development has recently embraced artificial intelligence (AI). The succeeding digital frontier in drug detection is quantum computing (QC).
Read the paper
Related studies
- In silico toxicology protocols
- QM7-X, a comprehensive dataset of quantum-mechanical properties spanning the chemical space of small organic molecules
- Quantum Informed Machine-Learning Potentials for Molecular Dynamics Simulations of CO2's Chemisorption and Diffusion in Mg-MOF-74
- In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications
- mRNA codon optimization with quantum computers
- The computational power of the human brain
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.